|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,089,697 |
|
Indirect Shares
|
264,473 |
|
|
Direct
Value |
$8,309,557 |
|
|
Indirect Value
|
$120,004 |
|
|
Total
Shares |
1,354,170 |
|
|
Total
Value |
$8,429,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
372 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
Director |
|
2004-04-27 |
4 |
B |
$40.21 |
$108,635 |
D/D |
2,700 |
106,698 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2004-05-04 |
4 |
B |
$39.85 |
$107,600 |
D/D |
2,700 |
109,398 |
2.39 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,799 |
163,233 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2018-05-10 |
4 |
S |
$4.60 |
$12,949 |
I/I |
(2,815) |
265,720 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-03-05 |
4 |
D |
$85.97 |
$250,001 |
D/D |
(2,908) |
55,005 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-03-05 |
4 |
A |
$85.97 |
$250,001 |
I/I |
2,908 |
4,908 |
0 |
- |
|
MAXY |
Maxygen Inc |
Director |
|
2003-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,964 |
2,964 |
|
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2004-12-21 |
4 |
OE |
$9.75 |
$29,250 |
D/D |
3,000 |
315,426 |
|
- |
|
CELG |
Celgene Corp |
Director |
|
2014-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
111,837 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2008-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,200 |
85,604 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2024-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,523 |
124,566 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,570 |
86,488 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2018-06-13 |
4 |
A |
$2.04 |
$7,356 |
D/D |
3,606 |
475,324 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2004-02-24 |
4 |
OE |
$11.38 |
$46,776 |
D/D |
3,998 |
107,998 |
|
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2015-03-06 |
4 |
B |
$6.57 |
$26,280 |
D/D |
4,000 |
200,472 |
2.39 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
146,770 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-04-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,125 |
90,058 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-29 |
4 |
B |
$15.80 |
$66,706 |
D/D |
4,214 |
14,214 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2005-01-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,500 |
17,100 |
|
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2005-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500 |
108,899 |
|
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2018-06-07 |
4 |
A |
$2.00 |
$9,234 |
D/D |
4,611 |
451,435 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2013-08-14 |
4 |
OE |
$54.35 |
$251,369 |
D/D |
4,625 |
85,671 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,908) |
0 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2006-04-10 |
4 |
OE |
$4.88 |
$24,400 |
D/D |
5,000 |
602,094 |
|
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2011-04-05 |
4 |
GA |
$0.00 |
$0 |
D/D |
5,000 |
213,204 |
0 |
- |
|
372 Records found
|
|
Page 5 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|